Kawashima Y - Search Results

1

S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.

Harada K, Supriatno, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Int J Oncol. 2007 Feb;30(2):365-74. Int J Oncol. 2007. PMID: 17203218

2

High antitumor activity using intratumoral injection of plasmid DNA with mutant-type p27Kip1 gene following in vivo electroporation.

Harada K, Supriatno, Kawaguchi S, Onoue T, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Oncol Rep. 2005 Feb;13(2):201-6. Oncol Rep. 2005. PMID: 15645112

3

Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells.

Harada K, Supriatno, Kawashima Y, Itashiki Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Oral Oncol. 2005 Jul;41(6):623-30. doi: 10.1016/j.oraloncology.2005.02.007. Oral Oncol. 2005. PMID: 16050017

4

High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.

Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Anticancer Res. 2005 May-Jun;25(3c):2471-5. Anticancer Res. 2005. PMID: 16080478 Free article.

5

S-1, an oral fluoropyrimidine anti-cancer agent, enhanced radiosensitivity in a human oral cancer cell line in vivo and in vitro: involvement possibility of inhibition of survival signal, Akt/PKB.

Harada K, Kawaguchi S, Supriatno, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Cancer Lett. 2005 Aug 26;226(2):161-168. doi: 10.1016/j.canlet.2004.12.048. Cancer Lett. 2005. PMID: 16134238

6

High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.

Harada K, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Anticancer Res. 2006 Mar-Apr;26(2B):1615-9. Anticancer Res. 2006. PMID: 16619581 Free article.

7

Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.

Harada K, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: kawashima y. Oncol Rep. 2006 Jun;15(6):1417-23. Oncol Rep. 2006. PMID: 16685374

8

[A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].

Harada K, Kawashima Y, Uchida D, Yoshida H. Harada K, et al. Among authors: kawashima y. Gan To Kagaku Ryoho. 2007 May;34(5):745-7. Gan To Kagaku Ryoho. 2007. PMID: 17496449 Japanese.

9

Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.

Tamatani T, Azuma M, Motegi K, Takamaru N, Kawashima Y, Bando T. Tamatani T, et al. Among authors: kawashima y. Int J Oncol. 2007 Oct;31(4):761-8. Int J Oncol. 2007. PMID: 17786306

10

Association between diabetes-related clinical indicators and oral health behavior among patients with type 2 diabetes.

Yoshioka M, Kawashima Y, Noma Y, Fukui M, Yanagisawa S, Shirayama Y, Nagai K, Hinode D. Yoshioka M, et al. Among authors: kawashima y. J Med Invest. 2021;68(1.2):140-147. doi: 10.2152/jmi.68.140. J Med Invest. 2021. PMID: 33994459 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,119 results

Search Page

Filters